Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 • 4,082 citations
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1989 • 1,471 citations
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
2000 • 990 citations
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
2000 • 841 citations
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
2001 • 567 citations
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
2000 • 521 citations
Endocrine Treatment of Breast Cancer in Women
1990 • 403 citations
Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk
1999 • 348 citations
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
1996 • 341 citations
Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer
1996 • 258 citations
Tamoxifen and risk of idiopathic venous thromboembolism
1998 • 183 citations
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma
1998 • 170 citations
Menopause, oestrogens and arthritis
2000 • 136 citations
Pharmacokinetics of anastrozole and tamoxifen alone and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
2001 • 129 citations
[Aromatase inhibitors and arthralgia].
2011 • 59 citations
Gynaecological monitoring during tamoxifen therapy
1994 • 58 citations
Recent advances in endocrine therapy of breast cancer
1997 • 53 citations
Postchemotherapy rheumatism.
1993 • 43 citations
Rheumatoid Symptoms Following Breast Cancer Treatment
1999 • 27 citations
Future possibilities in the prevention of breast cancer: Breast cancer prevention trials
2000 • 26 citations
The effect of anastrozole (Arimidex™) on serum lipids — a randomized comparison of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal women with Advanced Breast Cancer
2001 • 25 citations
ADJUVANT TAMOXIFEN IN BREAST-CANCER-TREATMENT IN POSTMENOPAUSAL WOMEN - OCCURRENCE OF THROMBOEMBOLIC COMPLICATIONS
1994 • 22 citations
How are bisphosphonates used today in breast cancer clinical practice?
2001 • 8 citations
Cited By (0)
No citing papers found in database